Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.
about
Retinopathy of prematurity: Past, present and futureIGF-I in the clinics: Use in retinopathy of prematurityScreening and Treatment in Retinopathy of PrematurityThe mouse retina as an angiogenesis model.Retinopathy of prematurity: the need for prevention.Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity.A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gainRisk factors for retinopathy of prematurity: insights from outlier infants.Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurityPreliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.WINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infantsValidity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity.Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants.Weight at first detection of retinopathy of prematurity predicts disease severity.Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.A predictive score for retinopathy of prematurity in very low birth weight preterm infants.Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD).Revisiting the mouse model of oxygen-induced retinopathy.Nutrition, insulin-like growth factor-1 and retinopathy of prematurityEarly Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity.Current update on retinopathy of prematurity: screening and treatmentHyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity.Mechanisms and management of retinopathy of prematurity.The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain.Predictors of treatment-warranted retinopathy of prematurity in the SUNDROP cohort: influence of photographic features.Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model.Advances in understanding and management of retinopathy of prematurity.Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics.Predictive algorithms for early detection of retinopathy of prematurity.Postnatal weight gain in very low birth weight infants in Beijing and the risk of retinopathy of prematurity.Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity.WINROP algorithm for prediction of sight threatening retinopathy of prematurity: Initial experience in Indian preterm infants.Prediction of severe retinopathy of prematurity using the WINROP algorithm in a birth cohort in South East Scotland.WINROP can modify ROP screening praxis: a validation of WINROP in populations in Sörmland and Västmanland.Validation of the Colorado Retinopathy of Prematurity Screening Model.Assessment of WINROP algorithm as screening tool for preterm infants in Manitoba to detect retinopathy of prematurity.
P2860
Q26767012-1B4FA5D2-1335-44E6-918A-CB0A8602E05EQ28070089-B54C2059-E90C-43DF-85AA-E3BE6EA0C610Q28082541-F9BF85CD-CB97-487F-A94E-1712AD459F40Q30495106-6740B9F3-FECD-4012-B48B-BF22C4827E1CQ33585466-4615E8F2-427C-4F72-B2D4-B6AD1FB04AD2Q33760906-9B288057-EF9F-4007-9E51-ED6947E9972EQ33820526-CCE94E03-4B91-4F5F-A995-EFCF1E6E5C78Q34282973-C4275334-7D6F-4A6E-8F62-AF13913936C9Q34339456-19767E2A-F12B-4003-8B4A-07ED7BC7CEC5Q34343703-71CA9EE0-3562-46CE-B9A0-E97D6C41476AQ34358139-BEF1AD0E-89D8-42CC-85F0-830CEE96A28AQ34755438-AE734A6D-7FDB-416F-8AE7-AA6B9674F362Q34760190-3E4CA9CC-C58A-4BA8-A55C-AB24FD5E1067Q34998606-27028098-4669-41F4-84FE-B2818510131FQ35196060-ADA0D0AF-5342-441E-9B34-A836EC813E71Q35226655-A85FF163-AAB7-4FB5-85AF-BCAD167116FFQ35316451-17800057-C029-4807-A7F7-9CD3A421ABD9Q35370567-F809FB36-428A-45FF-8054-E83EBF8F3C16Q35820384-2F6BFE2A-4BF2-4543-9914-04B3D1E9736EQ36602045-9D8FE7BB-DDAB-4929-A236-8F2C4CDF7152Q37155762-A86DA272-F01B-4A74-AEEF-B049925A1443Q37258163-971ED983-5451-46E2-B633-46B390EE9292Q37443809-FDA0BC09-4509-42CB-B3C9-9F7C5723D3F6Q37819879-CDE61458-067D-4A96-98E8-3DEDEAF579FBQ37828361-B0078575-B9C0-499D-8CC1-FB08F59A01E0Q38069895-7CA10C1A-0394-4031-BF90-DD8500C0D903Q38110390-A1917E35-5DDB-46CB-9D4B-4E35B227ADA8Q38110394-03A06914-9441-4867-AA12-176FE0B80F2FQ38637787-BEA2554C-74B8-463D-85CC-6EEEA5CE7B60Q38675563-18616BB3-8B0D-4126-AAF0-DB082CEC2443Q39052915-2186AF0E-283F-4A0E-93B1-A67E77A25F42Q39084295-E6735F8D-36C6-41FD-9B6A-052E5A2AD39FQ40692698-30A9182A-913B-4FEA-9E4F-C4C3EF9A33F2Q43165622-D7068CB3-C56C-4A2C-A779-90D284A82516Q47190154-7604454F-0376-404B-A8E8-0B776BD290F4Q47570937-F18A85B1-9C6D-4E01-9B56-56F53363209EQ47679810-56D4FDED-A933-464E-A6B8-043EF9CBDC33Q51108401-0476EDBF-F55B-4969-82B8-34BE31FBACEDQ51739749-23725ECB-67A6-48AB-920B-3A3810A259A2Q55355197-645F4E12-9761-4DB2-91DA-B802776C34AB
P2860
Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Validation of a new retinopath ...... d insulinlike growth factor I.
@en
Validation of a new retinopath ...... d insulinlike growth factor I.
@nl
type
label
Validation of a new retinopath ...... d insulinlike growth factor I.
@en
Validation of a new retinopath ...... d insulinlike growth factor I.
@nl
prefLabel
Validation of a new retinopath ...... d insulinlike growth factor I.
@en
Validation of a new retinopath ...... d insulinlike growth factor I.
@nl
P2093
P1433
P1476
Validation of a new retinopath ...... d insulinlike growth factor I.
@en
P2093
Eva Andersson
Ingrid Hansen-Pupp
Kristina Holm
Lois E H Smith
P304
P356
10.1001/ARCHOPHTHALMOL.2009.69
P407
P577
2009-05-01T00:00:00Z